NDAORALTABLETPriority Review
Approved
Dec 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VASCOR (bepridil hydrochloride) is an oral calcium channel blocker approved in 1990 for the treatment of chronic stable angina. It works by inhibiting calcium influx into cardiac and vascular smooth muscle cells, reducing myocardial oxygen demand and improving coronary blood flow. The drug is indicated for patients who remain symptomatic despite other antianginal therapies.
LOE Approaching
With LOE approaching and minimal linked roles, this product faces significant commercial headwinds; career opportunities are likely limited to specialized retained teams focused on transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
VASCOR has zero linked job openings and faces imminent LOE, making it an unattractive career opportunity for growth-oriented professionals. Roles supporting this product are likely contracting or being consolidated into legacy/maintenance teams within Johnson & Johnson.
Brand ManagerField Sales Representative
Worked on VASCOR at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.